» Articles » PMID: 31036293

Molecular Signaling in Bone Cells: Regulation of Cell Differentiation and Survival

Overview
Publisher Elsevier
Specialty Biochemistry
Date 2019 May 1
PMID 31036293
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

The achievement of proper bone mass and architecture, and their maintenance throughout life requires the concerted actions of osteoblasts, the bone forming cells, and osteoclasts, the bone resorbing cells. The differentiation and activity of osteoblasts and osteoclasts are regulated by molecules produced by matrix-embedded osteocytes, as well as by cross talk between osteoblasts and osteoclasts through secreted factors. In addition, it is likely that direct contact between osteoblast and osteoclast precursors, and the contact of these cells with osteocytes and cells in the bone marrow, also modulates bone cell differentiation and function. With the advancement of molecular and genetic tools, our comprehension of the intracellular signals activated in bone cells has evolved significantly, from early suggestions that osteoblasts and osteoclasts have common precursors and that osteocytes are inert cells in the bone matrix, to the very sophisticated understanding of a network of receptors, ligands, intracellular kinases/phosphatases, transcription factors, and cell-specific genes that are known today. These advances have allowed the design and FDA-approval of new therapies to preserve and increase bone mass and strength in a wide variety of pathological conditions, improving bone health from early childhood to the elderly. We have summarized here the current knowledge on selected intracellular signal pathways activated in osteoblasts, osteocytes, and osteoclasts.

Citing Articles

Development and characterization of an fluorescently tagged 3D bone-cartilage interface model.

Adams M, Cottrell J Front Endocrinol (Lausanne). 2024; 15:1484912.

PMID: 39600948 PMC: 11588493. DOI: 10.3389/fendo.2024.1484912.


Insights and implications of sexual dimorphism in osteoporosis.

Zhang Y, Xie N, Sun X, Nice E, Liou Y, Huang C Bone Res. 2024; 12(1):8.

PMID: 38368422 PMC: 10874461. DOI: 10.1038/s41413-023-00306-4.


Exploring the Cellular and Molecular Mechanism of Discoidin Domain Receptors (DDR1 and DDR2) in Bone Formation, Regeneration, and Its Associated Disease Conditions.

Mariadoss A, Wang C Int J Mol Sci. 2023; 24(19).

PMID: 37834343 PMC: 10573612. DOI: 10.3390/ijms241914895.


Role of Cx43 on the Bone Cell Generation, Function, and Survival.

Plotkin L, Asad I, Kritikos A, Sanz N Bioelectricity. 2023; 5(3):188-195.

PMID: 37746312 PMC: 10517329. DOI: 10.1089/bioe.2023.0028.


Effect of periostin on bone metabolic and autophagy factors during tooth eruption in mice.

Qin H, Cai J Open Life Sci. 2023; 18(1):20220663.

PMID: 37589010 PMC: 10426264. DOI: 10.1515/biol-2022-0663.


References
1.
Garcia A, Tom C, Guemes M, Polanco G, Mayorga M, Wend K . ERα signaling regulates MMP3 expression to induce FasL cleavage and osteoclast apoptosis. J Bone Miner Res. 2012; 28(2):283-90. PMC: 3524410. DOI: 10.1002/jbmr.1747. View

2.
Mulari M, Vaaraniemi J, Vaananen H . Intracellular membrane trafficking in bone resorbing osteoclasts. Microsc Res Tech. 2003; 61(6):496-503. DOI: 10.1002/jemt.10371. View

3.
Plotkin L, Bellido T . Beyond gap junctions: Connexin43 and bone cell signaling. Bone. 2012; 52(1):157-66. PMC: 3513515. DOI: 10.1016/j.bone.2012.09.030. View

4.
Kantaputra P, Kapoor S, Verma P, Intachai W, Ketudat Cairns J . Split hand-foot malformation and a novel WNT10B mutation. Eur J Med Genet. 2018; 61(7):372-375. DOI: 10.1016/j.ejmg.2018.02.001. View

5.
Yagi M, Ninomiya K, Fujita N, Suzuki T, Iwasaki R, Morita K . Induction of DC-STAMP by alternative activation and downstream signaling mechanisms. J Bone Miner Res. 2007; 22(7):992-1001. DOI: 10.1359/jbmr.070401. View